Download PDF

Other users also viewed these articles

Cost evolution of biological drugs in rheumatoid arthritis patients in a tertiary hospital: Influential factors on price Mariángeles González Fernández; Elena Villamañán; Inmaculada Jiménez-Nácher; Francisco Moreno; Chamaida Plasencia; Francisco Gayá; Alicia Herrero; Alejandro Balsa;
Reumatol Clin. 2021;17:335-42
Effectiveness of a checklist for the control of the disease activity in patients with axial spondyloarthritis Raquel Almodóvar; Elia Pérez-Fernández; Marta Valero; Virginia Villaverde; Laura González; Beatriz Joven Ibáñez; Eva Tomero Muriel; Alejandro Prada Ojeda; M.a Teresa Navio; Laura Cebrián Méndez; Leticia Lojo; Ramón Mazzucchelli; Pedro Zarco Montejo;
Reumatol Clin. 2025;21:
Study of the impact of the inclusion of global pain and functional capacity assessment in the definition of remission and its maintenance for rheumatoid arthritis. Aims and methodology Alejandro Balsa; Daniel Seoane-Mato; Marta Domínguez-Álvaro; Mercedes Alperi; Virginia Ruiz-Esquide; Javier Bachiller-Corral; Federico Díaz-González;
Reumatol Clin. 2025;21: